{
  "id": 20371308,
  "title": "Ares Management LLC, director, buys $390,403 of Claritev Corp stock",
  "url": "https://urgent.news/2026/11/17/ares-management-llc-director-buys-390-403-of-claritev-corp-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-17T02:46:05.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ares-management-llc-director-buys-390403-of-claritev-corp-stock-93CH-5031511"
  },
  "original_language": "en",
  "account": "Ares Management LLC, a prominent investor and board member of Claritev Corp (NASDAQ:CTEV), recently bolstered its stake in the company by purchasing 13,587 shares of its Class A Common Stock. The transaction, completed on November 11, 2026, amounted to a total value of $390,403, with each share fetching $28.7336, significantly higher than the current market price of $24.99. This move comes despite the stock's volatile performance, as it has delivered an impressive 80% return over the past six months, even as it declined by 35% in the previous year.\n\nFollowing this acquisition, Ares Management LLC now indirectly owns a total of 2,063,105 shares of Claritev Corp Class A Common Stock, across various affiliated entities. While the stock currently appears overvalued, according to InvestingPro analysis, Ares Management LLC's strategy of aggressive share buybacks, one of ten ProTips offered to subscribers, may present potential value in the long term.\n\nClaritev Corp has recently reported robust financial results, with third-quarter revenue of $268.3 million, surpassing analyst estimates of $256.46 million. Despite this strong performance, the company reported an adjusted loss per share of $3.64, slightly below the expected $3.63. However, Claritev's sixth consecutive quarter of year-over-year revenue growth and the highest quarterly revenue in 17 quarters demonstrate the company's resilience and growth trajectory. Additionally, Claritev has raised its full-year earnings guidance, signaling continued financial strength.\n\nMarket analysts have taken note of these developments, with Piper Sandler raising the stock's price target to $82, maintaining an Overweight rating. The firm attributes this optimism to the implementation of the No Surprises Act, which has led to an 8.0% year-over-year increase in claims volume for the third quarter. These factors highlight Claritev's ongoing momentum in the market, making it an attractive prospect for investors.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}